C-arms are non-invasive imaging devices utilized for fluoroscopic intraoperative imaging during complex surgical and emergency care operations. They have image intensifiers and radiographic capabilities that help provide high-resolution X-ray images and allow surgeons to monitor operation progress in real-time. They also aid in the visualization of kidney drainage, gastroenterology, neurostimulation, percutaneous valve replacements, and repair of abdominal and thoracic aortic aneurysms.
The market worth of the c-arms market in 2021 was USD 1684.11 million, and it will be worth USD 2603.67 million by 2030, growing at a 4.96% CAGR during the forecast period.
The market for C-arms is expanding due to the growing elderly population and the increased demand for imaging technologies in the healthcare industry. The impact of lifestyle changes on people’s health might result in chronic conditions, including cancer, respiratory illnesses, and other conditions that require surgery for treatment, which will drive the market’s expansion.
The positive shift in c-arms market trends is due to the rising demand for minimally invasive treatments among patients and physicians. A C-Arms gadget can assist the surgeon in performing a precise and small incision on the patient because he cannot make a minute cut due to a restricted field of vision.
The demand for C-Arms devices has increased because of the rise of non-communicable (chronic) disease patients worldwide. As the need for patients with chronic conditions grows, C-Arms devices are being employed more frequently all over the world.
Due to their sophisticated features and functionalities, C-Arms typically cost over USD 200,000. Therefore, the more expensive devices and supporting equipment seriously impede industrial expansion.
Future market growth for C-Arms devices may benefit greatly from the recent applications. Intraoperative 3D, minimally invasive surgery, hybrid operating rooms, interventional angiography, abdominal and thoracic aortic aneurysm repair, cardiac surgery, vascular surgery, gastroenterology, and neurostimulation are a few of the procedures in which c-arms are used.
With a market share of 50% in 2021, the Fixed C-Arms segment led the sector. The demand for fixed C-arm applications has significantly expanded due to the fixed C-arms’ ongoing advances in clinical outcomes and usage flexibility. Additionally, because it produces such high-quality images, a fixed C-arm has typically been taken into consideration for an operating room. As a result, the market for mobile c-arms will expand at a CAGR of 5.2%.
Due to the increasing prevalence of musculoskeletal illnesses and the growing elderly population, the Orthopaedics And Trauma category held the highest industry size in 2021, with a share of over 20%. Due to their accuracy in the operating room, operability, high-quality imaging, and versatility, C-arms have numerous uses in orthopedics.
With a revenue share of about 38% in 2021, North America ruled the market for C-Arms. The industrial expansion in this area is driven by the rising acceptance of cutting-edge technologies, the ability to store purchased energy, enhanced healthcare infrastructure, and a just reimbursement framework.
With a CAGR of 4.5%, the Asia-Pacific region will have the quickest market growth. The region’s market expansion is further accelerated by the expanding need for better imaging technology and the accompanying government requirements for healthcare improvement.
- Siemens Healthineers AG
- GE Healthcare
- Koninklijke Philips NV
- Canon Medical Systems Corporation
- Hologic, Inc.
- DMS Imaging
- ATON GmbH (Ziehm Imaging, Inc. and OrthoScan, Inc.)
- Shimadzu Corporation
- C-Arms International
The market worth of the c-arms market in 2021 was USD 1684.11 million, and it will be worth USD 2603.67 million by 2030, growing at a 4.96% CAGR during the forecast period. The major factor influencing the demand for c-arms around the world is the rising number of people having surgical procedures as a result of the rising prevalence of chronic diseases. Additionally, the growing elderly population with ailments including cancer, heart disease, and arthritis is accelerating the demand for surgical operations.